CASPIAN研究: Durvalumab联合化疗为广泛期小细胞肺癌患者带来总生存期获益
Durvalumab Plus Platinum-Etoposide versus Platinum-Etoposide in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer(CASPIAN): A Randomised, Controlled, Open-Label, Phase 3 Trial
CASPIAN研究: Durvalumab联合化疗为广泛期小细胞肺癌患者带来总生存期获益 |
|
评价者:吴雨微 |
Durvalumab Plus Platinum-Etoposide versus Platinum-Etoposide in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer(CASPIAN): A Randomised, Controlled, Open-Label, Phase 3 Trial |
| |